電子鼻市場シェア分析、業界動向と統計、成長予測 2026-2031年

電子鼻（エレクトロニックノーズ）市場の規模は、2025年の1億4,628万米ドルから2026年には1億6,421万米ドルへと拡大し、2026年から2031年にかけて年平均成長率（CAGR）12.26%で推移し、2031年には2億9,274万米ドルに達するとMordor Intelligenceでは予測しています。市場の成長を牽引しているのは、MEMS（微小電気機械システム）センサーアレイの小型化、ニューロモーフィックAIアルゴリズムの導入、そしてヘルスケア、食品安全、環境モニタリングといった分野での利用拡大です。高速な臭気検知技術は、ミリ秒単位の応答速度により哺乳類の嗅覚に匹敵するレベルに達しており、リアルタイム診断への適用が可能になっています。北米は、呼気診断を支援する規制環境を背景に、2024年時点で電子鼻市場の30.5%のシェアを占めています。一方、アジア太平洋地域は、製造業や農業における品質管理ニーズの高まりにより、CAGR 14.0%という最も高い成長率を示しています。エンドユーザー別に見ると、食品・飲料分野が収益の35.3%を占める一方、ヘルスケア分野は、呼気を用いた疾患検査の実用化が進んでいることから、CAGR 13.6%という最も高い成長率を記録しています。

レポートの主なポイント

• エンドユーザー別では、2025年に食品・飲料分野が収益シェア34.92%で市場を主導し、ヘルスケア分野は2031年までCAGR 13.42%で成長すると予測されています。
• センサー技術別では、2025年に金属酸化物半導体アレイが電子鼻市場シェアの41.58%を占め、電界非対称イオン移動度分析（FAIMS）技術は2031年までCAGR 13.68%で拡大すると予測されています。
• 用途別では、2025年に品質管理および賞味期限予測が電子鼻市場規模の32.18%を占め、疾患診断分野は2031年までCAGR 13.95%で成長が進む見込みです。
• 地域別では、2025年に北米が収益の30.12%を占め、アジア太平洋地域は2031年までCAGR 13.72%で推移すると予測されています。

センサー技術別：MOSの優位性に挑むFAIMS

金属酸化物（MOS）アレイは、その確かな信頼性と1ダイあたり1ドル未満という低価格を背景に、2025年の電子鼻市場で41.58%のシェアを占めました。酸化スズや酸化亜鉛のナノ粒子を組み込んだハイブリッド構造は、ホルムアルデヒドやアンモニアの監視においてppb（10億分の1）レベルの感度を実現しています。電場非対称イオン移動度分析（FAIMS）は、高選択性が求められる呼気診断や爆発物検知の用途で研究機関への導入が進み、年平均成長率（CAGR）13.68%を記録しています。

水晶振動子マイクロバランス（QCM）センサーは、医薬品のブリスターパックの完全性確認など、水分感応性が重要な用途で主流となっています。一方、導電性高分子センサーは常温で動作する特性から、ウェアラブル機器の設計者から注目を集めています。本質安全防爆構造が必須とされる石油精製所や海洋プラットフォーム向けには、光学式検出器や光イオン化検出器が採用されています。機械学習を活用したセンサーフュージョン技術により、複雑な臭気成分の識別精度は99%にまで向上しており、精密医療におけるFAIMSの有用性がさらに高まっています。

用途別：市場の力学を変える「疾患診断」

品質管理および賞味期限予測は、2025年の電子鼻市場規模の32.18%を占め、食肉、乳製品、酒類、化粧品メーカーなどで利用されています。クラウドベースのダッシュボードにより、MES（製造実行システム）と連携したリアルタイムの合否判定が可能になっています。現在、収益全体の10.62%を占める疾患診断分野は、肺がん、COPD（慢性閉塞性肺疾患）、嚢胞性線維症に関する臨床的検証の蓄積に伴い、CAGR 13.95%で拡大していく見通しです。

Electronic Nose Market Analysis by Mordor Intelligence

The electronic nose market size is expected to grow from USD 146.28 million in 2025 to USD 164.21 million in 2026 and is forecast to reach USD 292.74 million by 2031 at 12.26% CAGR over 2026-2031. Strong momentum arises from miniaturized MEMS sensor arrays, neuromorphic AI algorithms, and increasing deployment across healthcare, food safety, and environmental monitoring. High-speed odor detection now matches mammalian olfaction with millisecond response times, making the technology viable for real-time diagnostics. North America holds a 30.5% electronic nose market share in 2024 on the back of supportive regulatory frameworks for breath diagnostics. Meanwhile, the Asia-Pacific is the fastest-growing region at 14.0% CAGR, fueled by quality control demands in manufacturing and agriculture. Across end-user verticals, food and beverage commands 35.3% revenue while healthcare shows the highest 13.6% CAGR, driven by validated breath-based disease tests.

Key Report Takeaways

• By end-user vertical, food and beverage led with 34.92% revenue share in 2025, while healthcare is projected to advance at a 13.42% CAGR through 2031.
• By sensor technology, metal-oxide semiconductor arrays captured 41.58% of the electronic nose market share in 2025; field asymmetric ion mobility spectrometry is forecast to expand at a 13.68% CAGR to 2031.
• By application, quality control and shelf-life prediction accounted for a 32.18% share of the electronic nose market size in 2025, and disease diagnosis is moving forward at a 13.95% CAGR through 2031.
• By geography, North America held 30.12% revenue in 2025, whereas Asia-Pacific is tracking a 13.72% CAGR through 2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.

Global Electronic Nose Market Trends and Insights

Driver Impact Analysis*

Rapid Miniaturization and Cost Decline of MEMS Sensor Arrays

MEMS-based systems now fit on credit-card footprints while maintaining >95% detection accuracy. Standardized semiconductor packaging and expanded wafer fabs in China, South Korea, and Taiwan have shaved 40-60% off unit costs since 2022. Tungsten-trioxide nanorod heaters enable 0.5–1 s identification, far outpacing legacy 10–30 s platforms.[1]Duty-cycling strategies cut power draw to 160 µW at 250 °C, opening battery-operated and wearable use cases. The net result: entry barriers fall and the electronic nose market penetrates consumer electronics, telehealth, and smart-home ecosystems.

Integration of Neuromorphic AI for Real-Time Pattern Recognition

Spiking neural networks modeled on the mammalian olfactory bulb accomplish >97% classification accuracy with <16 ms latency on 1 mW ASICs.[2] Large-language-model extensions fuse chemical signatures with contextual metadata, sharpening selectivity for overlapping VOC profiles. Edge implementations trim cloud traffic, critical for hazardous-gas alerts in mining and process plants. Online active-learning loops counter sensor drift, keeping long-term accuracy above 90% without manual recalibration. These breakthroughs underpin the next wave of autonomous odor-analysis devices across defense, healthcare, and industrial safety.

Heightened Bio-security Mandates in Agri-Exporting Nations

Washington’s FY 2025 Chemical and Biological Defense Program budgets USD 1.66 billion toward advanced detection technologies.[3] Electronic nose systems detect bark-beetle infestations at 95% accuracy, preventing multimillion-dollar timber losses in Europe and North America. Grain-storage operators deploy VOC sensors to isolate insect outbreaks and optimize fumigation timing. Export certificates in China, Brazil, and Australia increasingly require continuous olfactory monitoring to avoid trade disruptions. Integration with satellite crop-health data yields holistic bio-security dashboards, expanding the electronic nose market in smart-agriculture ecosystems.

VOC-Based Disease Diagnostics Gaining Regulatory Fast-Track

The FDA’s emergency authorizations for COVID-19 breath tests established precedent for expedited VOC-diagnostic approvals.[4] Clinical trials on >10,000 patients achieved 93-98% accuracy in lung-cancer detection via breath, equaling gold-standard imaging. The NIOX platform’s clearance for asthma therapy monitoring further signals regulator openness to non-invasive olfactory tools. Governments in the EU, Japan, and Israel draft specific performance benchmarks, cutting time-to-market for medical device makers. Healthcare providers see cost reductions and patient-experience benefits, spurring hospital adoption and driving electronic nose market growth.

Restraints Impact Analysis*

Sensor Drift and Calibration Complexity in Harsh Environments

Metal-oxide sensors exhibit pronounced baseline drift under humidity and temperature swings, forcing quarterly recalibration that inflates operating costs.[5] Seven-year field studies confirm performance erosion necessitating sensor replacement in refinery stacks and landfills. Wavelet-decomposition and machine-learning compensation reach 100% identification over one-year horizons but demand embedded computing power, raising the bill of materials. While one-class drift schemes cut calibration samples by 70%, they still rely on controlled training cycles. Industries requiring 24/7 uptime, such as petrochemical processing, view these maintenance burdens as adoption barriers.

Data-Privacy Concerns for Breath-Biopsy Health Records

Breath analysis outputs are classified as protected health information under HIPAA and GDPR, obligating encryption, consent tracing, and localized data storage. Hospital CIOs cite integration challenges with electronic medical record systems that were never designed for high-frequency chemical fingerprints. Cross-border data flows complicate clinical trials for multinational device makers, adding legal overhead. Cybersecurity audits now form part of procurement checklists, elongating sales cycles. These factors temper short-term healthcare deployments, although emerging privacy-preserving federated-learning frameworks promise relief.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By End-user Vertical: Healthcare Drives Future Growth

Healthcare is projected to post a 13.42% CAGR through 2031. Breath-based oncology screening and asthma-monitoring devices drive demand, supported by favorable reimbursement pilots in the United States and Germany. Food and beverage remains the largest vertical, leveraging e-noses for meat freshness, wine oxidation, and dairy adulteration checks. Adoption spreads from processing plants to quick-service restaurants, integrating cloud dashboards for daily product audits.

Military, defense, and homeland security made up 9.05% revenue in 2025, propelled by toxic-gas detection requirements within NATO and Asia-Pacific defense modernization. Waste-management operators deploy odor sensors to comply with landfill emission caps in EU member states. Industrial safety and HVAC companies embed arrays in ventilation systems for 24/7 CO₂ and VOC tracking, reducing sick-building complaints. Overall, healthcare’s elevated CAGR positions it to eclipse food and beverage revenue post-2030.

By Sensor Technology: FAIMS Challenges MOS Dominance

Metal-oxide arrays held a 41.58% electronic nose market share in 2025 on account of proven reliability and sub-USD 1 per die pricing. Hybrid stacks incorporating tin-oxide and zinc-oxide nanoparticles deliver ppb-level sensitivity for formaldehyde and ammonia monitoring. Field asymmetric ion mobility spectrometry clocks a 13.68% CAGR as laboratories adopt it for high-selectivity breath diagnostics and explosive detection.

Quartz crystal microbalance sensors dominate moisture-sensitive applications like pharmaceutical blister-pack integrity, while conducting polymers attract wearables designers due to room-temperature operation. Emerging optical and photo-ionization detectors serve refinery and offshore platforms where intrinsic safety is mandatory. Machine-learning-driven sensor fusion tightens classification accuracy to 99% in complex odor matrices, reinforcing FAIMS’ appeal in precision medicine.

By Application: Disease Diagnosis Transforms Market Dynamics

Quality control and shelf-life prediction 32.18% of the electronic nose market size in 2025, serving meat, dairy, spirits, and cosmetics producers. Cloud-based dashboards enable real-time pass/fail flags that sync with MES systems. Disease diagnosis, currently 10.62% of revenue, will expand at a 13.95% CAGR as clinical validation stacks up for lung cancer, COPD, and cystic fibrosis.

Hazardous-gas detection remains a core industrial safety segment with 11.67% revenue, fueled by stricter methane-emissions rules in North America and Europe. Indoor-air-quality monitoring benefits from the post-pandemic emphasis on ventilation and workplace wellness. Research and academic testing increase steadily as universities secure grants to explore VOC biomarkers for Alzheimer’s and sepsis.

Complete Report Scope:

• By End-user Vertical
  • Military and Defence
  • Healthcare
  • Food and Beverage
  • Waste Management (Environmental Monitoring)
  • Industrial Safety and HVAC
• By Sensor Technology
  • Metal-Oxide Semiconductor (MOS)
  • Quartz Crystal Microbalance (QCM)
  • Field Asymmetric Ion Mobility Spectrometry (FAIMS)
  • Conducting Polymer
  • Optical and Photo-Ionisation
• By Application
  • Disease Diagnosis (Breath Analysis)
  • Quality Control and Shelf-life Prediction
  • Hazardous Gas Detection
  • Indoor Air Quality Monitoring
  • Research and Academic Testing
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-East Asia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Rest of Africa

Geography Analysis

North America generated 30.12% of the electronic nose market, underpinned by NIH grants and early FDA clearances for breath diagnostics. Defense and homeland-security spending on chemical-threat detection further stimulates demand. Academic-industry collaborations at institutions such as Stanford and MIT accelerate new-product pipelines.

Asia-Pacific is projected to clock the fastest 13.72% CAGR as China, Japan, and India digitize food-supply chains and smart-factory lines. Semiconductor manufacturing hubs in Taiwan and South Korea offer cost-effective fabs for MEMS die, lowering regional ASPs. Local start-ups in Shenzhen and Bengaluru use edge AI to tailor low-cost modules for curry freshness, rice-wine quality, and urban air pollution use cases.

Europe is sustained by EN 13725:2022 odor-emission enforcement that obliges industrial sites to deploy continuous monitoring. The region’s agri-exporters integrate e-noses in bio-security protocols to protect trade with the Middle East and Asia. In South America and the Middle East, and Africa, the demand for electronic nose is driven by agricultural export inspection and oil-and-gas methane detection respectively, albeit from a lower base.

Regulatory Landscape

Electronic nose systems operate under sector-specific regulation rather than a single global framework. In environmental monitoring, deployments in Europe often follow broader compliance expectations for automatic measuring systems and quality assurance, including EN 14181:2014 and EN 15267:2009. Odor monitoring and testing methodologies are further addressed through engineering guidance such as VDI/VDE 3518-3:2018 for odor-related measurements using electronic noses. For indoor air and building applications, ISO methods such as ISO 16000-29:2014 provide test approaches relevant to VOC detector performance, shaping procurement requirements for IAQ and workplace monitoring programs.

In healthcare and breath diagnostics, regulatory and privacy requirements affect both product development and data handling. Breath analysis outputs are treated as protected health information under frameworks such as HIPAA and GDPR, consistent with the market adoption constraints described in this report, and FDA emergency authorizations for COVID-19 breath tests have set precedent for expedited pathways for VOC-based diagnostics. In food and beverage quality and safety, acceptance depends on demonstrating equivalence and reproducibility relative to established food safety criteria overseen by agencies such as the FDA and EFSA. This reinforces the need for standardized data acquisition, validation, and calibration practices before routine use expands beyond human sensory panels.

Value Chain Analysis

The electronic nose value chain begins with upstream materials and components, including metal-oxide, conducting polymer, QCM, and FAIMS-related sensor elements, along with MEMS packaging and micro-heaters that influence performance and power draw. Midstream players design and assemble sensor arrays, sampling modules, and embedded electronics, then pair them with pattern-recognition software and cloud or edge analytics. Differentiation has shifted toward AI training, sensor-fusion, and drift-compensation workflows. Calibration gases, reference methods, and periodic field services also remain key inputs, since drift and environmental variability directly affect total cost of ownership.

Downstream, system integrators and automation partners embed e-nose modules into factory systems, instruments, and monitoring networks for end users across food processing, healthcare, industrial safety, waste management, and defense. The value chain increasingly includes hardware-plus-software subscription models (odor-as-a-service / SmellTech-as-a-Service), where recurring revenue links to model updates and remote monitoring. Recent partner-led scaling shows this approach in practice, with Ainos working with ASE Technology Holding for backend semiconductor facilities and with industrial computing and automation partners such as NEXCOM and Kenmec, reflecting how adoption often depends on integration into existing smart-factory edge infrastructure rather than standalone device sales.

Competitive Landscape

Market fragmentation remains moderate: the top five vendors. MSA Safety fortified its position with the USD 200 million takeover of M&C TechGroup, bolstering process-gas analytics. Owlstone Medical secured USD 2.3 million from the Cystic Fibrosis Foundation to accelerate breath-based pathogen tests, highlighting investor appetite for niche healthcare platforms.

SICK transferred 800 employees to a joint venture with Endress+Hauser to leverage shared gas-analysis IP for refinery and chemical customers. Envirosuite drew a USD 10 million minority stake from Hitachi Construction Machinery to merge odor-monitoring with ESG mining platforms. Sensirion’s methane-monitor partnerships with Intero – The Sniffers and Sensible EDP demonstrate targeted vertical solutions.

Start-ups such as Plasmion and Aryballe specialize in FAIMS and silicon photonics, respectively, pursuing OEM licensing rather than end-product sales. Large tech firms experiment with odor sensing for mixed-reality and autonomous-vehicle cabins, though still at research and development stages. Overall, value migrates toward software analytics and application-specific customization rather than commodity hardware.

Market Opportunities and Future Outlook

Food quality, spoilage detection, and allergen screening remain a commercialization white space because they tie clear operational pain points to high-throughput sensing at the edge. In June 2026, University of California, Berkeley researchers reported a 16-sensor electronic nose array that classified foods, including fresh and spoiled dairy and meat, and detected allergens such as walnuts and peanuts with 92.6% accuracy. This reinforces a pathway from lab prototypes to in-line or consumer-adjacent screening, where current practice often relies on sampling, lab testing, or subjective checks. The opportunity supports continuous monitoring on processing lines, cold-chain checkpoints, and smart appliances, but it depends on vendors hardening solutions against complex background odors and establishing validation protocols.

Healthcare opportunity centers on non-invasive VOC diagnostics that reduce friction versus imaging or invasive sampling, but it is constrained by privacy, data governance, and regulator-aligned performance benchmarks. Scientific work continues to expand the biomarker map, and in July 2026, Scientific Reports described feasibility for metal-oxide electronic noses to differentiate bacterial species in biofilm-promoting blood cultures, with 100.0% accuracy for species with distinct volatile signatures. That points to use cases such as rapid triage support and therapy guidance where turnaround time matters. Across food and medical applications, the main unmet needs concentrate on standardized data acquisition and model validation, drift-resilient operation in uncontrolled environments, and integrated edge-to-cloud workflows that keep protected datasets compliant while still enabling continuous model improvement.

Recent Industry Developments

• June 2026: AIRSENSE Analytics GmbH announced a collaboration with Proengin to integrate AIRSENSE IMS technology into Proengin systems, highlighted around Eurosatory 2026. The move enhances interoperability in CBRNe detection stacks, supporting wider field deployment where procurement favors integrated platforms over standalone sensors.
• October 2025: Owlstone Medical won an award of up to USD 49.1 million from ARPA-H for the POSEIDON program to develop at-home multi-cancer early detection tests. This funding accelerates scale-up for breath-based VOC analytics and raises the bar for clinical validation, manufacturing readiness, and secure data workflows in breath diagnostics.
• September 2024: Owlstone Medical entered a five-year Research Collaboration Agreement with the US FDA Center for Devices and Radiological Health (CDRH) to develop methods for identifying volatile organic compounds in breath. The collaboration ties tool development to regulatory science, helping define measurement and validation approaches that can streamline future submissions for breath-based devices.

List of Companies Covered in this Report:

• Alpha MOS SA
• Electronic Sensor Technology Inc.
• Plasmion GmbH
• Envirosuite Ltd.
• The eNose Company BV
• Airsense Analytics GmbH
• Sensigent LLC
• Common Invent BV
• E-Nose Pty Ltd.
• Owlstone Medical Ltd.
• Smart Nanotubes Technologies GmbH
• Scentroid Inc.
• Oizom Instruments Pvt Ltd. (Odosense)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid miniaturisation and cost decline of MEMS sensor arrays
4.2.2 Integration of neuromorphic AI for real-time pattern recognition
4.2.3 Heightened bio-security mandates in agri-exporting nations
4.2.4 VOC-based disease diagnostics gaining regulatory fast-track
4.2.5 Odour-as-a-service platforms unlocking recurring revenue
4.2.6 Edge-to-cloud analytics lowering total cost of ownership
4.3 Market Restraints
4.3.1 Sensor drift and calibration complexity in harsh environments
4.3.2 Data-privacy concerns for breath-biopsy health records
4.3.3 Absence of harmonised global odour emission standards
4.3.4 Limited battery life in portable e-nose devices
4.4 Industry Supply Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Impact of Macroeconomic Factors on the Market
4.8 Porter’s Five Forces Analysis
4.8.1 Bargaining Power of Suppliers
4.8.2 Bargaining Power of Consumers
4.8.3 Threat of New Entrants
4.8.4 Threat of Substitutes
4.8.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
5.1 By End-user Vertical
5.1.1 Military and Defence
5.1.2 Healthcare
5.1.3 Food and Beverage
5.1.4 Waste Management (Environmental Monitoring)
5.1.5 Industrial Safety and HVAC
5.2 By Sensor Technology
5.2.1 Metal-Oxide Semiconductor (MOS)
5.2.2 Quartz Crystal Microbalance (QCM)
5.2.3 Field Asymmetric Ion Mobility Spectrometry (FAIMS)
5.2.4 Conducting Polymer
5.2.5 Optical and Photo-Ionisation
5.3 By Application
5.3.1 Disease Diagnosis (Breath Analysis)
5.3.2 Quality Control and Shelf-life Prediction
5.3.3 Hazardous Gas Detection
5.3.4 Indoor Air Quality Monitoring
5.3.5 Research and Academic Testing
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 South America
5.4.2.1 Brazil
5.4.2.2 Argentina
5.4.2.3 Rest of South America
5.4.3 Europe
5.4.3.1 Germany
5.4.3.2 United Kingdom
5.4.3.3 France
5.4.3.4 Rest of Europe
5.4.4 Asia-Pacific
5.4.4.1 China
5.4.4.2 Japan
5.4.4.3 India
5.4.4.4 South Korea
5.4.4.5 South-East Asia
5.4.4.6 Rest of Asia-Pacific
5.4.5 Middle East and Africa
5.4.5.1 Middle East
5.4.5.1.1 Saudi Arabia
5.4.5.1.2 United Arab Emirates
5.4.5.1.3 Rest of Middle East
5.4.5.2 Africa
5.4.5.2.1 South Africa
5.4.5.2.2 Egypt
5.4.5.2.3 Rest of Africa

6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 Alpha MOS SA
6.4.2 Electronic Sensor Technology Inc.
6.4.3 Plasmion GmbH
6.4.4 Envirosuite Ltd.
6.4.5 The eNose Company BV
6.4.6 Airsense Analytics GmbH
6.4.7 Sensigent LLC
6.4.8 Common Invent BV
6.4.9 E-Nose Pty Ltd.
6.4.10 Owlstone Medical Ltd.
6.4.11 Smart Nanotubes Technologies GmbH
6.4.12 Scentroid Inc.
6.4.13 Oizom Instruments Pvt Ltd. (Odosense)

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
7.1 White-space and Unmet-need Assessment

---

---